OBI Pharma (Taiwan) Analysis
| 4174 Stock | TWD 62.90 0.40 0.63% |
OBI Pharma is overvalued with Real Value of 52.84 and Hype Value of 62.9. The main objective of OBI Pharma stock analysis is to determine its intrinsic value, which is an estimate of what OBI Pharma is worth, separate from its market price. There are two main types of OBI Pharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect OBI Pharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of OBI Pharma's stock to identify patterns and trends that may indicate its future price movements.
The OBI Pharma stock is traded in Taiwan on Taiwan OTC Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. OBI Pharma is usually not traded on No Trading . Market opens only for Clearing & Settlement, Mid - autumn / Moon Festival, No Trading . Market opens only for Clearing & Settlement 2, Adjusted Holiday / Chinese New Year 's Eve, Chinese New Year 's Eve, Chinese New Year, Dragon Boat Festival, National Day of the Republic of China, Chinese New Year 2, Chinese New Year 3, Adjusted Holiday 1, Adjusted Holiday 2. OBI Stock trading window is adjusted to Asia/Taipei timezone.
OBI |
OBI Stock Analysis Notes
About 37.0% of the company shares are owned by insiders or employees . The book value of OBI Pharma was presently reported as 22.55. The company recorded a loss per share of 8.05. OBI Pharma had not issued any dividends in recent years. OBI Pharma, Inc., a bio-pharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. The company was founded in 2002 and is based in Taipei, Taiwan. OBI PHARMA operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. For more info on OBI Pharma please contact Michael Chang at 886 2 2655 8799 or go to https://www.obipharma.com.OBI Pharma Investment Alerts
| OBI Pharma generated a negative expected return over the last 90 days | |
| The company reported the revenue of 18.77 M. Net Loss for the year was (1.53 B) with loss before overhead, payroll, taxes, and interest of (25.59 M). | |
| OBI Pharma has accumulated about 3.57 B in cash with (1.06 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 17.92. | |
| Roughly 37.0% of the company shares are owned by insiders or employees |
OBI Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 17.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OBI Pharma's market, we take the total number of its shares issued and multiply it by OBI Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 27th of November, OBI Pharma holds the market risk adjusted performance of (0.98), and Variance of 5.39. OBI Pharma technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the entity's future prices. Please check OBI Pharma mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if OBI Pharma is priced fairly, providing market reflects its current price of 62.9 per share.OBI Pharma Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. OBI Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for OBI Pharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
OBI Pharma Outstanding Bonds
OBI Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. OBI Pharma uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most OBI bonds can be classified according to their maturity, which is the date when OBI Pharma has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
OBI Pharma Predictive Daily Indicators
OBI Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of OBI Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 6419.07 | |||
| Daily Balance Of Power | (0.44) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 62.95 | |||
| Day Typical Price | 62.93 | |||
| Price Action Indicator | (0.25) | |||
| Period Momentum Indicator | (0.40) |
OBI Pharma Forecast Models
OBI Pharma's time-series forecasting models are one of many OBI Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary OBI Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About OBI Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how OBI Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling OBI shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as OBI Pharma. By using and applying OBI Stock analysis, traders can create a robust methodology for identifying OBI entry and exit points for their positions.
OBI Pharma, Inc., a bio-pharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. The company was founded in 2002 and is based in Taipei, Taiwan. OBI PHARMA operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding OBI Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Additional Tools for OBI Stock Analysis
When running OBI Pharma's price analysis, check to measure OBI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OBI Pharma is operating at the current time. Most of OBI Pharma's value examination focuses on studying past and present price action to predict the probability of OBI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OBI Pharma's price. Additionally, you may evaluate how the addition of OBI Pharma to your portfolios can decrease your overall portfolio volatility.